This resolution expresses support for designating the last Tuesday of April each year as APOL1-Mediated Kidney Disease (AMKD) Awareness Day . It seeks to raise public awareness about AMKD, a rapidly progressive form of kidney disease that disproportionately affects individuals of Western and Central African ancestry due to specific genetic variants. The resolution highlights that kidney disease impacts millions of Americans, with Black individuals facing significantly higher rates of kidney failure. It emphasizes that variants in the APOL1 gene increase susceptibility to AMKD, often without symptoms until advanced stages, and that 13 percent of Black Americans have variants in both copies of the gene. To address this, the resolution encourages all United States residents to become better informed about kidney disease and AMKD. Specifically, it urges people from or with ancestry from Western and Central Africa to consider genetic testing for APOL1 gene mutations, enabling them to take proactive steps to protect their kidney health and reduce their risk of kidney failure.